Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Non-cash Items (2016 - 2025)

Historic Non-cash Items for CorMedix (CRMD) over the last 11 years, with Q3 2025 value amounting to $3.3 million.

  • CorMedix's Non-cash Items fell 5582.33% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 5582.33%. This contributed to the annual value of $23.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Non-cash Items of $3.3 million as of Q3 2025, which was down 5582.33% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Non-cash Items ranged from a high of $23.6 million in Q4 2024 and a low of $337075.0 during Q4 2021
  • Moreover, its 5-year median value for Non-cash Items was $6.5 million (2023), whereas its average is $6.6 million.
  • As far as peak fluctuations go, CorMedix's Non-cash Items surged by 25531.81% in 2021, and later tumbled by 9419.62% in 2025.
  • Quarter analysis of 5 years shows CorMedix's Non-cash Items stood at $337075.0 in 2021, then skyrocketed by 230.21% to $1.1 million in 2022, then soared by 483.98% to $6.5 million in 2023, then skyrocketed by 262.58% to $23.6 million in 2024, then crashed by 86.0% to $3.3 million in 2025.
  • Its Non-cash Items stands at $3.3 million for Q3 2025, versus $2.4 million for Q2 2025 and $530000.0 for Q1 2025.